OB-GYN 101
Pharmacy

Contents  ·  Introduction  ·  Learning Objectives  ·  Clinical Issues  ·  Procedures  ·  Library  ·  Pharmacy  ·  Lab  ·  Chest X-ray  ·  Ultrasound  ·  Videos  ·  Forms  ·  Progress Notes  ·  Facts Cards  ·  Students  ·  Search  ·  Feedback  ·  About Us

 

 

Methamphetamine (Desoxyn)

Category:

  • Miscellaneous

Description:

  • Anorexiant, CNS stimulant: DEA Schedule II

Indications:

  • Short term adjunct to caloric restriction in exogenous obesity (high abuse potential)

  • Attention deficit disorder with hyperactivity

Contraindications:

  • Hyperthyroidism, moderate to severe hypertension, glaucoma, sever arteriosclerosis

  • History of drug abuse, symptomatic cardiovascular disease, agitated states, within 14 days of MAOI administration

Precautions:

  • Pregnancy category C; use for medical conditions does not pose significant risk to the fetus for congenital anomalies, but mild withdrawal symptoms may be observed in newborn children ; contraindicated during breast feeding

  • Mild hypertension, child <3 years, Tourette’s disorder

  • Motor and phonic tics

  • Tartrazine sensitivity (15mg sustained release preparation)

Adverse Reactions (Side Effects):

  • CNS: addiction, aggressiveness, changes in libido, chills, dependence, dizziness, dyskinesia, dysphoria, euphoria, headache, hyperactivity, insomnia, irritability, over- stimulation, psychotic episodes, restlessness, talkativeness, tremor

  • CV: arrhythmias (at large doses), dysrhythmias, hypertension, palpitations, reflex decrease in heart rate, tachycardia

  • GI: anorexia, constipation, cramps, diarrhea, dry mouth, metallic taste, nausea, vomiting, weight loss

  • GU: impotence

  • METAB: reversible elevations in serum thyroxine with heavy use

  • SKIN: urticaria

 

 

 

Dosage:

Administered orally

  • Adult:            

    • Obesity: PO 5mg 30 minutes before each meal; SUS REL PO 10-15mg every morning; treatment should not exceed a few weeks

  • Child:            

    • Attention deficit disorder with hyperactivity: PO 5mg 1-2 times daily initially, increase in increments of 5 mg/day at weekly intervals until an optimum response is achieved; usual effective dose 20-25mg daily (divided twice daily with conventional tablets or once daily with sustained release formulations)

Drug interactions:

  • MAOIs: severe hypertensive reactions possible

  • Selegiline: Potential for enhanced pressor effect if used in combination

  • Sodium bicarbonate (large doses): inhibit elimination and increase the effect of amphetamines

 

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks. Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

OB-GYN 101: Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008 Medical Education Division, Brookside Associates, Ltd.
All rights reserved

 

Advertise on this site